Simplify Propel Opportunities ETF (SURI)
Holdings data is not available for this fund yet.
SURI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Sept. 30, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -13.14% | ▼ -9.99% |
| 3M | · | · |
| 6M | · | · |
| YTD | · | · |
| 1Y | · | · |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▼ -9.56% | ▼ -6.27% |
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 39 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| UNITED STATES OF AMERICA - BUREAU OF THE PUBLIC DEBT | 912797VM6 | $59.3M | 76.77 | 60,000,000 | DBT | US |
| PLAINS GP HOLDINGS LP | 72651A207 | $30.9M | 39.97 | 1,272,360 | EC | US |
| ACHIEVE LIFE SCIENCES INC | 004468500 | $9.4M | 12.11 | 1,432,105 | EC | US |
| MILESTONE PHARMACEUTICALS INC | 59935V107 | $4.5M | 5.81 | 3,349,379 | EC | CA |
| ACHIEVE LIFE SCIENCES INC | 004468187 | $3.4M | 4.42 | 966,667 | EC | US |
| DELCATH SYSTEMS INC | 24661P807 | $3.3M | 4.26 | 261,126 | EC | US |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | $2.7M | 3.50 | 249,267 | EC | US |
| CORCEPT THERAPEUTICS INC | 218352102 | $2.3M | 2.98 | 26,434 | EC | US |
| ABEONA THERAPEUTICS INC | 00289Y206 | $2.1M | 2.76 | 345,416 | EC | US |
| CELLDEX THERAPEUTICS INC | 15117B202 | $2.0M | 2.56 | 53,134 | EC | US |
| KYVERNA THERAPEUTICS INC | 501976104 | $1.6M | 2.11 | 182,603 | EC | US |
| COMPASS PATHWAYS PLC | 20451W101 | $1.6M | 2.09 | 114,281 | EC | GB |
| LEONABIO INC | 04746L203 | $1.4M | 1.78 | 149,279 | EC | US |
| INVENTIVA SA | 46124U107 | $1.2M | 1.53 | 313,483 | EC | FR |
| AQUESTIVE THERAPEUTICS INC | 03843E104 | $1.2M | 1.50 | 278,723 | EC | US |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | $983K | 1.27 | 101,355 | EC | US |
| ZEVRA THERAPEUTICS INC | 488445206 | $966K | 1.25 | 67,372 | EC | US |
| ORCHESTRA BIOMED HOLDINGS INC | 68572M106 | $947K | 1.23 | 219,387 | EC | US |
| PALISADE BIO INC | 696389402 | $942K | 1.22 | 450,543 | EC | US |
| TELESAT CANADA / TELESAT LLC | 87952VAR7 | $895K | 1.16 | 1,000,000 | DBT | CA |
| OCULAR THERAPEUTIX INC | 67576A100 | $796K | 1.03 | 81,051 | EC | US |
| ACHIEVE LIFE SCIEN RTS | · | $748K | 0.97 | 247,593 | EC | US |
| EYEPOINT INC | 30233G209 | $649K | 0.84 | 45,409 | EC | US |
| IMMUNIC INC | 4525EP200 | $472K | 0.61 | 30,725 | EC | US |
| UPSTREAM BIO INC | 91678A107 | $430K | 0.56 | 62,113 | EC | US |
| Akero Therapeutics Inc | 009CVR044 | $427K | 0.55 | 145,609 | EC | US |
| SAB BIOTHERAPEUTICS INC | 78397T202 | $409K | 0.53 | 104,849 | EC | US |
| OVID THERAPEUTICS INC | 690469101 | $260K | 0.34 | 96,817 | EC | US |
| ALTIMMUNE INC | · | $3K | 0.00 | 79,075 | EC | US |
| CHINOOK THERAPEUTICS INC | 169CVR016 | $2K | 0.00 | 25,000 | EC | US |
| Eiger BioPharmaceuticals Inc | 28249U204 | $900 | 0.00 | 90,000 | EC | US |
| MILESTONE PHARMACE WTS | · | $2 | 0.00 | 1,842,974 | EC | US |
| JASPER THERAPEUTIC WTS | · | $1 | 0.00 | 609,053 | EC | US |
| WTS - TENAYA THERAPEUTICS | · | $1 | 0.00 | 560,000 | EC | US |
| QUOIN PHARMACEUTIC WTS | · | $0 | 0.00 | 34,895 | EC | US |
| QUOIN PHARMACEUTIC WTS | · | $0 | 0.00 | 34,895 | EC | US |
| QUOIN PHARMACEUTIC WTS | · | $0 | 0.00 | 34,895 | EC | US |
| QUOIN PHARMACEUTIC WTS | · | $0 | 0.00 | 34,895 | EC | US |
| MORGAN STANLEY & CO. LLC | · | -$58.1M | -75.22 | -58,112,171 | RA | US |
Dividends 15 payments
| Ex-date | Amount / share |
|---|---|
| Sept. 25, 2026 | $0.6800 |
| June 25, 2026 | $0.6800 |
| March 26, 2026 | $0.6800 |
| Dec. 23, 2025 | $0.6800 |
| Sept. 25, 2025 | $0.6800 |
| June 25, 2025 | $0.6800 |
| March 26, 2025 | $0.6800 |
| Dec. 23, 2024 | $0.6800 |
| Sept. 25, 2024 | $0.6800 |
| June 25, 2024 | $1.2500 |
| March 25, 2024 | $0.6800 |
| Dec. 26, 2023 | $0.6800 |
| Sept. 27, 2023 | $0.6800 |
| June 27, 2023 | $0.6800 |
| March 27, 2023 | $1.0000 |
Institutional owners (13F) 1 filer
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | $221,164 | 100.00% | 12,359 | Shares | June 30, 2026 |